“…Our results from 38 patients with 42 identified prostate cancer tumors demonstrate that strong negative correlations are observable between GS and MD based tumor DTI measures in agreement with [ 14 – 16 ] and the ratios of these measures. On the other hand, our results show weak positive correlations or no significant correlations between GS and FA based DTI measures including the ratios.…”
Section: Discussionsupporting
confidence: 79%
“…On the other hand, our results show weak positive correlations or no significant correlations between GS and FA based DTI measures including the ratios. Beside, contradicting correlations between GS and FA have been reported in the literature: strong positive correlation [ 14 ], weak correlation with a very low value of the correlation coefficient [ 15 ], or no significant correlation [ 16 ]. Among all measures studied, the ratio of minimum MD from prostate tumor foci and noncancerous PZ prostate tissue shows the highest correlation with GS.…”
Section: Discussionmentioning
confidence: 99%
“…Current clinical applications of DTI for prostate cancer are focused predominantly on differentiation of tumor from normal prostate gland [ 7 – 13 ] and slightly on the assessment of tumor aggressiveness with respect to GS [ 14 – 16 ]. A wide range of MD and FA values from prostate tumor foci has been reported.…”
.Purpose. To evaluate the aggressiveness of peripheral zone prostate cancer by correlating the Gleason score (GS) with the ratio of the diffusion tensor imaging (DTI) measures. Materials and Methods. Forty-two peripheral zone prostate tumors were imaged using DTI. Regions of interest focusing on the center of tumor foci and noncancerous tissue were used to extract statistical measures of mean diffusivity (MD) and fractional anisotroy (FA). Measure ratio was calculated by dividing tumor measure by noncancerous tissue measure. Results. Strong correlations are observable between GS and MD measures while weak correlations are present between GS and FA measures. Minimum tumor MD (MD min ) and the ratio of minimum MD (rMD min ) show the same highest correlation with GS (both = −0.73). Between GS ≤ 7 (3 + 4) and GS ≥ 7 (4 + 3), differences are significant for all MD measures but for some FA measures. MD measures perform better than FA measures in discriminating GS ≥ 7 (4 + 3). Conclusion. Ratios of MD measures can be used in evaluation of peripheral zone prostate cancer aggressiveness; however tumor MD measures alone perform similarly.
“…Our results from 38 patients with 42 identified prostate cancer tumors demonstrate that strong negative correlations are observable between GS and MD based tumor DTI measures in agreement with [ 14 – 16 ] and the ratios of these measures. On the other hand, our results show weak positive correlations or no significant correlations between GS and FA based DTI measures including the ratios.…”
Section: Discussionsupporting
confidence: 79%
“…On the other hand, our results show weak positive correlations or no significant correlations between GS and FA based DTI measures including the ratios. Beside, contradicting correlations between GS and FA have been reported in the literature: strong positive correlation [ 14 ], weak correlation with a very low value of the correlation coefficient [ 15 ], or no significant correlation [ 16 ]. Among all measures studied, the ratio of minimum MD from prostate tumor foci and noncancerous PZ prostate tissue shows the highest correlation with GS.…”
Section: Discussionmentioning
confidence: 99%
“…Current clinical applications of DTI for prostate cancer are focused predominantly on differentiation of tumor from normal prostate gland [ 7 – 13 ] and slightly on the assessment of tumor aggressiveness with respect to GS [ 14 – 16 ]. A wide range of MD and FA values from prostate tumor foci has been reported.…”
.Purpose. To evaluate the aggressiveness of peripheral zone prostate cancer by correlating the Gleason score (GS) with the ratio of the diffusion tensor imaging (DTI) measures. Materials and Methods. Forty-two peripheral zone prostate tumors were imaged using DTI. Regions of interest focusing on the center of tumor foci and noncancerous tissue were used to extract statistical measures of mean diffusivity (MD) and fractional anisotroy (FA). Measure ratio was calculated by dividing tumor measure by noncancerous tissue measure. Results. Strong correlations are observable between GS and MD measures while weak correlations are present between GS and FA measures. Minimum tumor MD (MD min ) and the ratio of minimum MD (rMD min ) show the same highest correlation with GS (both = −0.73). Between GS ≤ 7 (3 + 4) and GS ≥ 7 (4 + 3), differences are significant for all MD measures but for some FA measures. MD measures perform better than FA measures in discriminating GS ≥ 7 (4 + 3). Conclusion. Ratios of MD measures can be used in evaluation of peripheral zone prostate cancer aggressiveness; however tumor MD measures alone perform similarly.
“…Note that we report MD values higher than expected from previous studies 41 . There are at least four different factors that could explain this: the data analysis model, the image resolution, the effective diffusion time, and the relaxation weighting.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
“…All the seven T 2 w‐extracted radiomic features were highly ranked (1–7) by MRMR when compared to the ADC‐extracted attributes (8–10). Although a substantial number of recent publications reference the value of DWI for PCa grading, our findings might be explained by the lower initial resolution of the available ADC maps compared to the corresponding T 2 w scans.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.